| Adam Peter Calusic, DO | |
|
215 Washington St, Grafton, WI 53024 | |
| (262) 375-3700 | |
| (262) 375-6306 |
| Full Name | Adam Peter Calusic |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 45 Years |
| Location | 215 Washington St, Grafton, Wisconsin |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1790713436 | NPI | - | NPPES |
| O002395 | Other | GATEWAY | |
| 0006805790004 | Medicaid | PA | |
| 100061643 | Medicaid | WI | |
| 50051256 | Other | BLUE CROSS | |
| 000161435 | Other | PA | HIGHMARK BLUE SHIELD |
| P00258005 | Other | RR MEDICARE | |
| 0038505000 | Other | BLUE SHIELD | |
| 4663112 | Other | PA | AETNA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 66284 (Wisconsin) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Aurora Advanced Healthcare Inc | 3375625833 | 929 |
News Archive
Corventis, Inc., a developer of wireless cardiovascular solutions designed to enable early detection, prevention and treatment of cardiovascular conditions, announced CE marking for the company's AVIVO™ Mobile Patient Management System. Physicians and patients in the European Union and other countries that accept CE Mark now have access to the company's noninvasive, wireless solution to evaluate physiological changes and monitor signs of cardiac irregularities in patients away from the hospital.
Human muscle-derived cells, pluripotent stem cells found in muscle, have been used to cure stress urinary incontinence in animal models, a finding which signals that these cells are prime candidates to treat the condition in adults.
The Berlin-based diagnostics company ifp Institut für Produktqualität has sold its molecular biological, PCR-based food test product line to QIAGEN at a price not revealed. QIAGEN has purchased all the required patents and licences and will immediately begin to market and distribute the newly acquired portfolio of 70 molecular biological tests. With the support of this powerful and experienced partner in food diagnostics ifp can now make available its expertise in food analytics globally.
The U.S. Food and Drug Administration's approval of the tuberculosis (TB) drug Sirturo, also known as bedaquiline, "appears to be just the first step in an exciting renaissance for TB drug development," Mark Harrington, executive director of Treatment Action Group (TAG), writes in the Bill & Melinda Gates Foundation's "Impatient Optimists" blog.
› Verified 7 days ago
| Entity Name | Aurora Advanced Healthcare Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265629133 PECOS PAC ID: 3375625833 Enrollment ID: O20080123000694 |
News Archive
Corventis, Inc., a developer of wireless cardiovascular solutions designed to enable early detection, prevention and treatment of cardiovascular conditions, announced CE marking for the company's AVIVO™ Mobile Patient Management System. Physicians and patients in the European Union and other countries that accept CE Mark now have access to the company's noninvasive, wireless solution to evaluate physiological changes and monitor signs of cardiac irregularities in patients away from the hospital.
Human muscle-derived cells, pluripotent stem cells found in muscle, have been used to cure stress urinary incontinence in animal models, a finding which signals that these cells are prime candidates to treat the condition in adults.
The Berlin-based diagnostics company ifp Institut für Produktqualität has sold its molecular biological, PCR-based food test product line to QIAGEN at a price not revealed. QIAGEN has purchased all the required patents and licences and will immediately begin to market and distribute the newly acquired portfolio of 70 molecular biological tests. With the support of this powerful and experienced partner in food diagnostics ifp can now make available its expertise in food analytics globally.
The U.S. Food and Drug Administration's approval of the tuberculosis (TB) drug Sirturo, also known as bedaquiline, "appears to be just the first step in an exciting renaissance for TB drug development," Mark Harrington, executive director of Treatment Action Group (TAG), writes in the Bill & Melinda Gates Foundation's "Impatient Optimists" blog.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Adam Peter Calusic, DO 215 Washington St, Grafton, WI 53024-1700 Ph: (262) 375-3700 | Adam Peter Calusic, DO 215 Washington St, Grafton, WI 53024 Ph: (262) 375-3700 |
News Archive
Corventis, Inc., a developer of wireless cardiovascular solutions designed to enable early detection, prevention and treatment of cardiovascular conditions, announced CE marking for the company's AVIVO™ Mobile Patient Management System. Physicians and patients in the European Union and other countries that accept CE Mark now have access to the company's noninvasive, wireless solution to evaluate physiological changes and monitor signs of cardiac irregularities in patients away from the hospital.
Human muscle-derived cells, pluripotent stem cells found in muscle, have been used to cure stress urinary incontinence in animal models, a finding which signals that these cells are prime candidates to treat the condition in adults.
The Berlin-based diagnostics company ifp Institut für Produktqualität has sold its molecular biological, PCR-based food test product line to QIAGEN at a price not revealed. QIAGEN has purchased all the required patents and licences and will immediately begin to market and distribute the newly acquired portfolio of 70 molecular biological tests. With the support of this powerful and experienced partner in food diagnostics ifp can now make available its expertise in food analytics globally.
The U.S. Food and Drug Administration's approval of the tuberculosis (TB) drug Sirturo, also known as bedaquiline, "appears to be just the first step in an exciting renaissance for TB drug development," Mark Harrington, executive director of Treatment Action Group (TAG), writes in the Bill & Melinda Gates Foundation's "Impatient Optimists" blog.
› Verified 7 days ago
Lauren Weasler, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2061 Cheyenne Ct, Grafton, WI 53024 Phone: 262-376-1934 | |
Lester Ferra, M.D Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 975 Port Washington Rd, Grafton, WI 53024 Phone: 262-329-1000 | |
Dr. Jaime Diaz Cabatingan, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2061 Cheyenne Ct, Grafton, WI 53024 Phone: 262-376-1934 Fax: 262-375-2076 | |
Mark D Shewczyk, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2061 Cheyenne Ct, Grafton, WI 53024 Phone: 262-376-1934 |